The Biden Rally

As most of my readers know, I reserve Saturday mornings for writing my weekly newsletter. This week, however, Saturday morning marks the arrival of...

Pfizer Develops a Vaccine…Implications for Tailwinds

On Monday morning, Pfizer (PFE) announced that they have a very effective vaccine for Covid-19. This, combined with what appears to be a clear...

Moving Week

What do Donald Trump and I have in common? We are both in the process of moving... This week we found out that Joe Biden...

TFFP, INMB, OTRK…Earnings Logjam At Tailwinds

Yesterday afternoon, to my sheer delight, three companies in which I and/or my readers have large holdings all reported earnings at the same time....

TFF Pharmaceuticals Reports Third Quarter 2020 Financial and Business Results

AUSTIN, Texas--(BUSINESS WIRE)--Nov. 5, 2020-- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented...

TFF Pharmaceuticals and Felix Biotechnology Sign Letter of Intent for a Collaboration, Development and...

Tailwind's Take: further proof of both the versatility of the TFF process and the value add as Felix looks to be agreeing to $281...

TFF Pharmaceuticals, Inc. and Augmenta Bioworks, Inc. Enter Into a Worldwide Joint Development Agreement...

Tailwinds' Take: this is the 4th internal program for TFF and is a true breakthrough with their ability to deliver mABs directly to the...

Sell Mortimer, Sell!!!

What do I want to say? That's the question that comes into my head every Saturday morning. This newsletter is an opportunity. An opportunity...

TFF Pharmaceuticals Announces Positive Preclinical Results with University of Georgia Universal Influenza Vaccines

Tailwinds' Take: this is incredible news with the key being the ability to take an aluminum adjuvant vaccine and make a stable powder with...

TFF Pharmaceuticals Expands its cGMP Manufacturing Capabilities with Experic

Tailwinds' Take: why would Experic increase capacity for TFF's production? “We share their excitement in the continued advancement and expansion of their technology and...

Time for Small Cap to Shine?

Small and micro-cap stocks have underperformed the market for quite a while now. Since I started Tailwinds in August of 2016, the Russell 2000...

Pharmaceutics: Development of Remdesivir as a Dry Powder for Inhalation by Thin Film Freezing

Development of Remdesivir as a Dry Powder for Inhalation by Thin Film Freezing

TFF Firing on All Cylinders; An Update on TAC and CBD

It’s a big challenge to stay ahead of TFF Pharma (TFFP) as they have multiple ongoing programs, each seemingly more exciting than the rest....

TFF Pharmaceuticals Updates Progress of Human Clinical Trial with Tacrolimus Inhalation Powder

Tailwinds' Take: These data increases my market/commercial expectations for TFF Tacrolimus. I originally based my commercial forecasts on capturing a share of the lung...

Post Traumatic Investment Disease Redux? Nah, Just A Dose Of Reality

Having survived the rocky cliffs of Moab, I think I jinxed myself with last week's cover photo asking "What could go wrong?" Turns out...

This Week In Moab

Having written a newsletter for almost 200 consecutive weeks, I didn't want to miss this week. But, I am mountain biking in Moab Utah,...

The Final Push…

Like the debate, 2020 has been a sh**-show. Pandemics, political divisiveness, fires...it's not been a beach party to say the least. Yet, here we stand...

Wrapping Up A Chaotic Week

Markets were very volatile this past week, trading back and forth like a game of ping-pong. There's little doubt in my mind that the...

TFF Pharmaceuticals Comments on Animal Studies in the Development of High Potency Remdesivir as...

Tailwinds' Take: TFF's technology is truly disruptive to the delivery of 40% of the world's therapeutics. This paper should compel Gilead to consider their...

West Bound and Down

After fortuitously sheltering in place on the east coast for seven weeks, we are heading back for CA this week. We seem to have,...

TFF Pharmaceuticals Announces Topline Results of Voriconazole Inhalation Powder Phase 1 Clinical Trial

Tailwinds' Take: very exciting news. TFF's inhaled version of Voriconazole, if approved, will be the first inhaled antifungal. This is the ideal medication for...

Under The Radar…Key Data-Points From The Last Week That Nobody Really Noticed

The easiest way to make money in the market is trading off of insider information. It is also highly illegal, will put you in...

What’s Next for TFF?

TFF Pharma (Nasdaq: TFFP) had a big summer. First came the news about an internal program that appears to successfully reformulate Gilead’s Remdesivir into...

Goodbye August (almost)…

Okay, I know it's not the official end of August...that takes place on Monday. However, due to the fact that the month is basically...

This Week at Tailwinds

Stocks continued to climb the proverbial wall of worry last week, with the S&P briefly managing to touch an all-time high and the Russell...

TFFP: The Tip Of The Iceberg

Last night TFF Pharmaceuticals (TFFP) announced a worldwide exclusive licensing agreement with UNION therapeutics A/S (UNION) for its Thin Film Freezing drug delivery technology...

TFF Pharmaceuticals Enters into Worldwide Licensing Agreement with UNION therapeutics for its Thin Film...

Tailwinds' Take: we are very excited about the potential for niclosamide as a treatment for Covid-19. This is great news and is more evidence...

TFF Pharmaceuticals Announces $25.9 Million in Financing to Further Advance Its Thin Film Freezing...

Tailwinds' Take: very positive as the Company now has the financial strength to undertake more approvals via the 505(b)(2) pathway, which would be the...

OnTrak For A Great Year

Telehealth was the all the rage this past week. First The Centers for Medicare & Medicaid Services (CMS) is proposing changes to expand telehealth...

July Recap, August Preview…Best Month Yet at Tailwinds

Here I am on my first plane flight since Covid became a word used in our everyday vernacular. Things seem pretty much the same...

TFF Pharmaceuticals Announces Completion of Dosing for Voriconazole Inhalation Powder Phase 1 Clinical Trial

Tailwinds' Take: in our opinion, it's becoming increasingly clear that TFF can reformulate any non-water soluble drug for administration via an inhaler. We believe...

TFF Pharmaceuticals Comments on Research on the Re-formulation of Remdesivir to a Dry Powder...

Tailwinds' Take: we believe the work done on an inhalable version of remdesivir is groundbreaking and Gilead will eventually license TFF's process. AUSTIN, Texas--(BUSINESS WIRE)--Jul....

TFFP Applies Thin Film Freezing to Remdesivir with Outstanding Results

This morning in a non-peer reviewed paper available online, it has been shown that TFF Pharmamaceuticals, in conjunction with the University of Texas at...

Random Thoughts on a Number of Stocks…

There's certainly a lot going on in the world at large right now and none of it seems too good. Covid-19 refuses to go...

Previewing the 2nd Half of 2020…and Other Updates From The Week

Greetings from...wait for it...Ashland Oregon. Yes, it was so good, we came back for more. The weather here is great, the riding is outstanding...

TFF Pharmaceuticals Announces First Human Dosing With Tacrolimus Inhalation Powder and Topline Data for...

Tailwinds' Take: TFF's unique drug delivery platform is proving itself to be safer and more efficacious than pill or oral delivery. The Company has...

Summer is Coming

When you receive this newsletter, it will be June 21st, the official start of summer. Typically for stocks you have a summer doldrums, "sell...

TFF Pharmaceuticals Receives Orphan Drug Designation for Tacrolimus Inhalation Powder

Tailwinds' Take: the most important takeaway here is the execution of the team at an early stage company. TFFP is poised to disrupt pharma...

Three Disruptive Plays…And Other Thoughts From Last Week

The world of micro-cap is full of little stocks with big ideas. It seems like a large number of these companies have no sales,...

June Preview…Plus Much More!

May was another strong month for the market as the stimulus package and expectations for a strong re-opening of the economy kept the rebound...

Bada Bing Bada Boom

As if on cue, the market took a turn lower last week. This will be but a quick note on the market, as I'm...

TFF Pharmaceuticals Reports First Quarter 2020 Financial and Business Results

AUSTIN, Texas--(BUSINESS WIRE)--May 14, 2020--TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented...

The Eye Of The Storm…This Week In Tailwinds’ World

Well, I've been expecting it and it appears that it's here. The market put up one of its best months ever in April, but...

TFF Pharmaceuticals’ Inventor Dr. Robert O. Williams III Presents Session on Repurposing Niclosamide for...

Tailwinds' Take: this is potentially huge news. This quote, "Niclosamide has been shown to be considerably more potent when compared with other drugs such...

This Week in Stocks

While the markets may not have had the most volatile week of the year, nor come close, it was a very topsy-turvy five days...

Saturday Morning Ramblings…

Another great week in the market. The economy is in free-fall, unemployment is skyrocketing and stocks can't stop going up. How is this possible?...

TFF Pharmaceuticals Announces Cooperative Research and Development Agreement (CRADA) with the United States Army...

Tailwinds' Take: this quote from CEO Mattes says it all, “This CRADA, with the world’s preeminent biodefense research organization, is another validation of Thin...

This Week In MicroCap

It was certainly a great week for the market as a number of positive factors contributed to the continuation of what is a very...

IF Alpha?

My biggest concern last fall was, "what if Bernie gets into office?" This fear was driven partially by the fact that the market would...

TFF Pharmaceuticals Reports Fourth Quarter Results and Full Year 2019 Financial and Business Results

AUSTIN, Texas--(BUSINESS WIRE)--Mar. 26, 2020-- TFF Pharmaceuticals, Inc. (NASDAQ:TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin...

There’s Blood In The Streets…

Normally I love my Saturday mornings. This is when I write the weekly newsletter and it gives me a chance to review the prior...

TFF Pharmaceuticals Announces Phase 1 Clinical Trial Progress for Voriconazole Inhalation Powder to Treat...

Tailwinds' Take: Voriconazole is a generic liquid or tablet that is ingested for diseases like IPA, which start in the lungs. Having a direct...

It’s Definitely a Beer Market

Sometimes a typo can hit the sweet spot, right? When I got the text that we're entering a beer market...well, let's just say that...

TFF Pharmaceuticals Announces Engagement of J.S. Cole & Associates as Strategic Advisor for Partnering...

Tailwinds' Take: very interesting that they have engaged two firms for partnership efforts, first in China, now Japan. We continue to believe that this...

TFF Pharmaceuticals: Particle Engineering to Take Drug Development to the Next Level

TFF Pharmaceuticals has much more promise than meets the eye. Upon inspection, their thin film freezing technology enables an improved drug delivery platform that...

TFF Pharmaceuticals Announces Engagement of Torreya Partners, LLC as Strategic Advisor for Partnering Efforts...

AUSTIN, Texas--(BUSINESS WIRE)-- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film...

TFF Pharmaceuticals Reports Continued Progress Across Programs in Corporate Update

AUSTIN, Texas--(BUSINESS WIRE)--Jan. 28, 2020-- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented...

Ascend Capital Founder Malcolm Fairbairn Appointed to TFF Pharmaceuticals Board of Directors

AUSTIN, Texas--(BUSINESS WIRE)--Jan. 28, 2020-- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented...
DFC Advisory Services LLC (dba Tailwinds Research) is a registered investment adviser. Information presented is for educational purposes only and does not intend to make an offer or solicitation for the sale or purchase of any specific securities, investments, or investment strategies. Investments involve risk and unless otherwise stated, are not guaranteed. Be sure to first consult with a qualified financial adviser and/or tax professional before implementing any strategy discussed herein. Past performance is not indicative of future performance.